Tag Archives: Earnings

Onyx Bullish in 2012 Outlook

With an all-important FDA decision on carfilzomib scheduled for July 27, Onyx hopes to graduate to the next stage of commercial success. For a feature-length profile of Onyx and CEO Tony Coles, click here. Following on a strong 4Q report, Onyx Pharmaceuticals’ CEO Tony Coles said the company hopes to transform itself from a one-product […]
Posted in FDA, Market Access, People, pricing, R&D, Regulatory, Strategy | Also tagged , , | Leave a comment

Lower Lilly Earnings the Shape of Things to Come

Eli Lilly announced its first quarter financial results on April 19. But even though the company trumpeted a global revenue growth rate of 9 percent—$5.49 billion, compared to Q1 2009’s $5.05 billion—net income fell 5 percent to $1.25 billion. Part of the blame for that 4 percent difference, the company said, lies with the passage […]
Posted in Strategy | Also tagged , , , , , | Leave a comment
  • Categories

  • Meta